Next, considering DCs, Bell et al. reported immature CD1a+ to be retained intratumorally, and mature CD83+ DCs to be confined to peritumoral areas in patients with BC; nonetheless, the study was performed with only 32 samples and no statistical analyses were carried out (Bell et al., 1999). This evidence concerns the gene CD83 and breast cancer.